Publications

2024

• INHBA is enriched in HPV-negative oropharyngeal squamous cell carcinoma and promotes cancer progression.
  Abou Kors T, Hofmann L, Betzler A, Payer K, Bens M, Truong J, von Witzleben A, Thomas J, Kraus JM, Kalaajieh R, Huber D, Ezić J, Benckendorff J, Greve J, Schuler PJ, Ottensmeier CH, Kestler HA, Hoffmann TK, Theodoraki MN, Brunner C, Laban S
  Cancer Res Commun 2024 (epub ahead of print)
  

2023

• Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers.
  Huber* LT, Kraus* JM, Ezić* J, Wanli A, Groth M, Laban S, Hoffmann TK, Wollenberg B, Kestler** HA, Brunner** C
  Explor Target Antitumor Ther 2023, 4(3), 422–446 * equal contribution, ** co-corresponding authors
  
• The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.
  Mühlenbruch L, Abou-Kors T, Dubbelaar ML, Bichmann L, Kohlbacher O, Bens M, Thomas J, Ezić J, Kraus JM, Kestler HA, von Witzleben A, Mytilineos J, Fürst D, Engelhardt D, Doescher J, Greve J, Schuler PJ, Theodoraki MN, Brunner C, Hoffmann TK, Rammensee HG, Walz JS, Laban S
  Br J Cancer 2023, 128(9), 1777-87
  
• A protocol for the use of cloud-based quantum computers for logical network analysis of biological systems.
  Weidner FM, Rossini M, Ankerhold J, Kestler HA
  STAR Protoc 2023, 4(3), 102438
  
• Leveraging quantum computing for dynamic analyses of logical networks in systems biology.
  Weidner FM, Schwab JD, Wölk S, Rupprecht F, Ikonomi N, Werle SD, Hoffmann S, Kühl M, Kestler HA
  PATTERNS 2023, 4(3), 100705